First Line Therapy with Fludarabine Combinations in 42 Patients with Either Post Myelodysplastic Syndrome or Therapy Related Acute Myeloid Leukaemia-Reference-Cited by-同舟云学术

First Line Therapy with Fludarabine Combinations in 42 Patients with Either Post Myelodysplastic Syndrome or Therapy Related Acute Myeloid Leukaemia

Published:2001-01 Issue:3-4 Volume:40 Page:305-313
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Clavio Marino,Gatto Simona,Beltrami Germana,Cerri Raffaella,Carrara Paola,Pierri Ivana,Canepa Letizia,Miglino Maurizio,Balleari Enrico,Masoudi Bahman,Damasio Eugenio,Ghio Riccardo,Sessarego Mario,Gobbi Marco

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428190109057929

Reference34 articles.

1. AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial

2. Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome.

3. Stem Cell Transplantation for Secondary Acute Myeloid Leukemia: Evaluation of Transplantation as Initial Therapy or Following Induction Chemotherapy

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FLAI induction regimen in elderly patients with acute myeloid leukemia;Leukemia & Lymphoma;2019-06-04

2. Intesive fludarabine-high dose cytarabine-idarubicin combination as induction therapy with risk-adapted consolidation may improve treatment efficacy in younger Acute Myeloid Leukemia (AML) patients: Rationales, evidences and future perspectives;BioScience Trends;2017

3. Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia;Acta Haematologica;2016-11-03

4. High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients;American Journal of Hematology;2016-06-15

5. ASSESSMENT OF EFFECTIVENESS OF FLUDARABINE-CONTAINING CHEMOTHERAPY PROGRAMS IN ONCOHEMATOLOGICAL PATIENTS;Health and Ecology Issues;2014-06-28